DR NELLY KAMWALEKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 diabetes and obesity. Two drugs, Semaglutide and Tirzepatide ...

According to a recent study, nearly three in four Americans are overweight. Worse, this report predicts that for decades to ...

Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...

This new class of GLP-1 weight loss drugs may feel like a miracle, but it still takes effort from you for these meds to work safely and effectively.

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

GLP-1 receptor agonist drugs like Ozempic help people manage type 2 diabetes. Foods like Greek yogurt and avocados can't do ...

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...